129 related articles for article (PubMed ID: 29658570)
1. JWA suppresses the invasion of human breast carcinoma cells by downregulating the expression of CXCR4.
Xu L; Cheng L; Yang F; Pei B; Liu X; Zhou J; Zhu Y; Wang S
Mol Med Rep; 2018 Jun; 17(6):8137-8144. PubMed ID: 29658570
[TBL] [Abstract][Full Text] [Related]
2. Effects of the JWA gene in the regulation of human breast cancer cells.
Chen X; Feng J; Ge Z; Chen H; Ding W; Zhu W; Tang X; Chen Y; Tan Y; Ma T
Mol Med Rep; 2015 May; 11(5):3848-53. PubMed ID: 25586271
[TBL] [Abstract][Full Text] [Related]
3. JWA loss promotes cell migration and cytoskeletal rearrangement by affecting HER2 expression and identifies a high-risk subgroup of HER2-positive gastric carcinoma patients.
Qian J; Zhu W; Wang K; Ma L; Xu J; Xu T; Røe OD; Li A; Zhou J; Shu Y
Oncotarget; 2016 Jun; 7(24):36865-36884. PubMed ID: 27167206
[TBL] [Abstract][Full Text] [Related]
4. RNF185 modulates JWA ubiquitination and promotes gastric cancer metastasis.
Qiu D; Wang Q; Wang Z; Chen J; Yan D; Zhou Y; Li A; Zhang R; Wang S; Zhou J
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1552-1561. PubMed ID: 29481911
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
[TBL] [Abstract][Full Text] [Related]
6. JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.
Xu W; Chen Q; Wang Q; Sun Y; Wang S; Li A; Xu S; Røe OD; Wang M; Zhang R; Yang L; Zhou J
Cell Death Dis; 2014 Dec; 5(12):e1551. PubMed ID: 25476899
[TBL] [Abstract][Full Text] [Related]
7. JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer.
Chen Y; Huang Y; Huang Y; Xia X; Zhang J; Zhou Y; Tan Y; He S; Qiang F; Li A; Re OD; Li G; Zhou J
Carcinogenesis; 2014 Feb; 35(2):442-51. PubMed ID: 24072772
[TBL] [Abstract][Full Text] [Related]
8. JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling.
Bai J; Zhang J; Wu J; Shen L; Zeng J; Ding J; Wu Y; Gong Z; Li A; Xu S; Zhou J; Li G
Oncogene; 2010 Feb; 29(8):1227-37. PubMed ID: 19946336
[TBL] [Abstract][Full Text] [Related]
9. JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma.
Lu J; Tang Y; Farshidpour M; Cheng Y; Zhang G; Jafarnejad SM; Yip A; Martinka M; Dong Z; Zhou J; Xu J; Li G
Carcinogenesis; 2013 Dec; 34(12):2778-88. PubMed ID: 24064223
[TBL] [Abstract][Full Text] [Related]
10. A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4.
Zhan Y; Zhang H; Li J; Zhang Y; Zhang J; He L
J Cell Mol Med; 2015 Jul; 19(7):1614-23. PubMed ID: 25753200
[TBL] [Abstract][Full Text] [Related]
11. EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells.
Li Y; Shen X; Wang X; Li A; Wang P; Jiang P; Zhou J; Feng Q
Sci Rep; 2015 Jun; 5():11009. PubMed ID: 26046674
[TBL] [Abstract][Full Text] [Related]
12. ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients.
Lu J; Tang Y; Cheng Y; Zhang G; Yip A; Martinka M; Dong Z; Zhou J; Li G
Br J Cancer; 2013 Nov; 109(11):2842-52. PubMed ID: 24157826
[TBL] [Abstract][Full Text] [Related]
13. JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton.
Chen H; Bai J; Ye J; Liu Z; Chen R; Mao W; Li A; Zhou J
Cell Signal; 2007 Jun; 19(6):1315-27. PubMed ID: 17336041
[TBL] [Abstract][Full Text] [Related]
14. JWA--a novel environmental-responsive gene, involved in estrogen receptor-associated signal pathway in MCF-7 and MDA-MB-231 breast carcinoma cells.
Chen R; Li A; Zhu T; Li C; Liu Q; Chang HC; Zhou J
J Toxicol Environ Health A; 2005 Mar; 68(6):445-56. PubMed ID: 15799245
[TBL] [Abstract][Full Text] [Related]
15. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
16. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
[TBL] [Abstract][Full Text] [Related]
17. JWA is required for the antiproliferative and pro-apoptotic effects of all-trans retinoic acid in Hela cells.
Mao WG; Liu ZL; Chen R; Li AP; Zhou JW
Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):816-24. PubMed ID: 16922813
[TBL] [Abstract][Full Text] [Related]
18. MDM2 is a useful prognostic biomarker for resectable gastric cancer.
Ye Y; Li X; Yang J; Miao S; Wang S; Chen Y; Xia X; Wu X; Zhang J; Zhou Y; He S; Tan Y; Qiang F; Li G; Røe OD; Zhou J
Cancer Sci; 2013 May; 104(5):590-8. PubMed ID: 23347235
[TBL] [Abstract][Full Text] [Related]
19. JWA enhances As₂O₃-induced tubulin polymerization and apoptosis via p38 in HeLa and MCF-7 cells.
Shen L; Xu W; Li A; Ye J; Zhou J
Apoptosis; 2011 Nov; 16(11):1177-93. PubMed ID: 21847655
[TBL] [Abstract][Full Text] [Related]
20. [The effects of CXCR4 inhibited by RNA interference on metastasis and invasion of breast cancer cell in vitro].
Zhang SC; Qiao L; Gao H
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):473-5. PubMed ID: 17686306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
